Upstream Bio, Inc. UPB Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Upstream Bio, Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Upstream Bio, Inc.'s accrued expenses and other liabilities?
- Upstream Bio, Inc. (UPB) reported accrued expenses and other liabilities of $11.24M in Q1 2026.
- How has Upstream Bio, Inc.'s accrued expenses and other liabilities changed year-over-year?
- Upstream Bio, Inc.'s accrued expenses and other liabilities increased by 171.3% year-over-year, from $4.14M to $11.24M.
- What is the long-term trend for Upstream Bio, Inc.'s accrued expenses and other liabilities?
- Over 2 years (2023 to 2025), Upstream Bio, Inc.'s accrued expenses and other liabilities has grown at a 49.4% compound annual growth rate (CAGR), from $4.48M to $10.01M.